Publication & Citation Trends
Most Cited Works
Publications
185 total
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease PDF
Cited by 1,955
OpenAlex
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Cited by 506
OpenAlex
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup PDF
Cited by 815
OpenAlex
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Cited by 695
OpenAlex
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease PDF
Cited by 736
OpenAlex
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Cited by 653
OpenAlex
Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials
Cited by 969
OpenAlex
Research Topics
Dementia and Cognitive Impairment Research
(74)
Alzheimer's disease research and treatments
(72)
Health Systems, Economic Evaluations, Quality of Life
(24)
Cholinesterase and Neurodegenerative Diseases
(20)
Parkinson's Disease Mechanisms and Treatments
(12)
Frequent Co-Authors
Affiliations
Supélec
University of Southern California
Roche (Switzerland)
Biogen (United States)
Albert Einstein College of Medicine